An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Unfortunately, there isn't an enzyme for many reactions we would sorely like to catalyze—things like digesting plastics or ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Researchers have used artificial intelligence (AI) to design brand-new enzymes that can go through multi-step reactions, a ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Discover how AI tools like AlphaFold and RF Diffusion are revolutionizing protein folding design, medicine, and ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...